Senti Biosciences (SNTI)
NASDAQ:SNTI
US Market
Holding SNTI?
Track your performance easily

Senti Biosciences (SNTI) Financial Statements

94 Followers

Senti Biosciences Financial Overview

Senti Biosciences's market cap is currently ―. The company's EPS TTM is $-12.646; its P/E ratio is -0.17; Senti Biosciences is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue---$ 338.00K$ 937.00K
Gross Profit--$ 500.00K$ 338.00K$ 687.00K
EBIT$ -11.20M$ -14.51M$ -7.53M$ -42.41M$ -18.75M
EBITDA$ -9.74M$ -13.05M$ -6.06M$ -40.69M$ -17.97M
Net Income Common Stockholders$ -11.20M$ -12.11M$ 8.73M$ -42.41M$ -18.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 15.86M$ 23.72M$ 35.93M$ 39.43M$ 59.63M
Total Assets$ 86.91M$ 102.19M$ 119.48M$ 131.77M$ 143.63M
Total Debt$ 35.74M$ 36.72M$ 37.67M$ 37.31M$ 38.24M
Net Debt$ 19.88M$ 13.00M$ 1.74M$ -2.12M$ -21.39M
Total Liabilities$ 42.77M$ 46.09M$ 52.57M$ 48.83M$ 46.21M
Stockholders Equity$ 44.15M$ 56.09M$ 66.91M$ 82.94M$ 97.42M
Cash Flow-
Free Cash Flow$ -8.35M$ -11.70M$ -6.94M$ -17.42M$ -17.25M
Operating Cash Flow$ -8.35M$ -11.68M$ -7.04M$ -15.56M$ -13.58M
Investing Cash Flow-$ -15.00K$ 101.00K$ 21.34M$ 18.23M
Financing Cash Flow--$ 556.00K$ -23.00K$ 281.00K
Currency in USD

Senti Biosciences Earnings and Revenue History

Senti Biosciences Debt to Assets

Senti Biosciences Cash Flow

Senti Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis